{"id":"W2051592657","doi":"10.1016/s0090-4295(02)01905-2","title":"Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia","year":2002,"lang":"en","type":"article","venue":"Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":734,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Dutasteride; Urology; Placebo; Dihydrotestosterone; Hyperplasia; Prostate; 5 Alpha-Reductase Inhibitor; Transrectal ultrasonography; Internal medicine; International Prostate Symptom Score; Gastroenterology; Finasteride; Lower urinary tract symptoms; Androgen; Hormone; Pathology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01625928519311195,"score_gpt":0.2664180101072144,"score_spread":0.2501587249141025,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}